Diabetes mellitus promotes NOX4 expression in the podocytes and the production of ROS, leads to the loss of podocytes, and damages glomeruli, which indicates that NOX4 is an attractive therapeutic target for DN (Rajaram et al., 2019). This evidence concerns the gene NOX4 and diabetes mellitus.